Life Sciences Horizons Brochure 2025 - Flipbook - Page 23
22
2025 Horizons Life Sciences and Health Care
Cybersecurity paramount in
cross-border clinical trials
While some countries´ regulations (including those
in Mexico) recognize the importance of international
collaboration, there is still a need to make progress in
regulating key aspects of cross-border partnerships,
such as the international transfer of personal health
data. We also see the need to establish heightened
cybersecurity measures to protect information in
digital environments as increasingly paramount
in 2025.
Data breaches are not the only vulnerabilities for which crossborder clinical trial organizations should be vigilant; the rise in
cybercrime, particularly ransomware attacks, have become a
significant threat. Indeed, cybercriminals may attack clinical
trials through other means besides ransomware, including
phishing attacks or through supply chain tampering. Although
cyberattacks are never 100% preventable, cross-border clinical
trial sponsors must be sure to:
implement a cybersecurity program,
maintain physical, technical and administrative cybersecurity
measures, and
train all the involved parties on the ever-evolving subject
of cyberthreats.
Cybersecurity is not only important to prevent risks and attacks in
clinical trials, but also to ensure the integrity of trial results, and to
maintain the accuracy and reliability of data through security
mechanisms including encryption, multi-factor authentication,
and intrusion detection.
Guillermo Larrea
Partner
Mexico City
Ernesto Algaba Reyes
Partner
Mexico City
